Safety and immunogenicity of an HIV vaccine trial with DNA prime and replicating vaccinia boost
{{output}}
Developing a safe and effective vaccine remains a global priority for ending the human immunodeficiency virus (HIV) pandemic. All HIV vaccine trials with protein, DNA, non-replication vector or their combinations failed in the past. We constructed the HIV-1 CN... ...
